… and the GSE84437 dataset were used to successfully validate the robustness of our signature
by qRTPCR. In summary, we developed a prognostic signature for GA, that shows better …

… that is prognostic for five-year overall survival and validate the … 32-gene signature is a
promising prognostic and predictive … patients and should be validated using large patient cohorts …

… Colorectal cancer remains a serious public health problem due to the poor prognosis. In
the present study, we attempted to develop and validate a prognostic signature to predict the …

… The critical goal of the present study was to develop and validate a prognostic signature for
overall survival of GC patients. We performed the current study according to the guidelines of …

… In the last step, we develop a prognostic signature named the immune-based prognostic
signature for OV (IPSOV) to combine the effects of each immune category in the training set. …

… Second, the new signature should show good predictive power over and above … Our
prognostic signature fulfills these 2 suggested criteria, as evidenced by validation of the signature in …

… on risk prediction models by prognostic signature based on multiple gene integration for …
a prognostic signature based on gene expression profile from public database and validate its …

Background Due to the phenotypic and molecular diversity of hepatocellular carcinomas (HCC),
it is still a challenge to determine patients’ prognosis. We aim to identify new prognostic …

… Overall workflow showing the scheme used to develop and validate the prognostic signature
to predict prognostic outcomes. Abbreviations: TCGA, The Cancer Genome Atlas; logFC, …

… To assess the prognostic value of this prognostic signature, we firstly estimated the
survival curves between the high- and low-risk groups by the Kaplan–Meier method using the …